Home › Mesothelioma › Missouri › St. Louis
Mesothelioma clinical trials in St. Louis, MO
4 studies for Mesothelioma are looking for participants at sites in and around St. Louis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
RecruitingObservational study
- Washington University, St Louis
A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma
RecruitingPhase 2
- Washington University (Data Collection Only), St Louis
Lead-212 PSV359 Therapy for Patients With Solid Tumors
RecruitingPhase 1/2
- Saint Louis University, St Louis
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
RecruitingPhase 1/2
- Washington University, St Louis
About Mesothelioma
Mesothelioma is a tumor of mesothelium, a tissue that lines lungs and other organs. Most people who get it have inhaled asbestos. Read the symptoms.
More about Mesothelioma on MedlinePlus
Mesothelioma trials in other cities
- Houston, TX15 studies
- New York City, NY10 studies
- Washington, DC9 studies
- Chicago, IL9 studies
- Boston, MA8 studies
- Nashville, TN8 studies
- Los Angeles, CA6 studies
- Arlington, VA6 studies
- Pittsburgh, PA6 studies
- Philadelphia, PA6 studies
- Seattle, WA6 studies
- Edison, NJ5 studies
Other studies in St. Louis
- Non-Small Cell Lung Cancer73 studies
- Breast Cancer64 studies
- Metastatic Cancer54 studies
- Colorectal Cancer50 studies
- Cancer (all types)46 studies
- Prostate Cancer46 studies
- Lung Cancer39 studies
- Ovarian Cancer38 studies
- Pancreatic Cancer33 studies
- Endometrial Cancer29 studies
- Head and Neck Squamous Cell Carcinoma28 studies
- Heart Failure26 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.